Eastern Cooperative Oncology Group: all 175 studies

Page 1 of 2. Open to participants first (7), then studies with results posted, then the rest; newest registration first within each.

• A Targeted Electronic Health Approach to Reduce Fear of Recurrence in Breast Cancer Survivors (FoRtitude)Not yet recruitingNCT07122492Not applicable
• Testing the Investigational Agent Combination of Daratumumab, Bortezomib, and Dexamethasone Compared to the Usual Treatment of Cyclophosphamide, Bortezomib, and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients With Kidney FailureRecruitingNCT07085728Phase 2
• Extended Clinical Follow up and Biospecimen Collection for Patients Enrolled in TAILORx and RxPONDER: A Companion ProtocolNot yet recruitingNCT06786585
• The ECOG-ACRIN SUPPORT Trial: Multilevel Intervention to Improve Diverse Enrollment in Cancer Clinical TrialsRecruitingNCT06756607Not applicable
• Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial ChemotherapyRecruitingNCT06724237Phase 3
• Testing the Use of Combination Therapy in Patients With Persistent Low Level Acute Myeloid Leukemia (AML) Following Initial TreatmentNot yet recruitingNCT05628623Phase 2
• Daratumumab for Chemotherapy-Refractory Minimal Residual Disease in T Cell ALLRecruitingNCT05289687Phase 2
• COVID-19 Related Financial Hardship and Distress in Women Who Decline TMIST (EA1151) ParticipationTerminatedNCT05076266Results posted
• Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell LymphomaActive, not recruitingNCT01415752Phase 2Results posted
• Early Surgery or Standard Palliative Therapy in Treating Patients With Stage IV Breast CancerCompletedNCT01242800Not applicableResults posted
• Induction Chemotherapy Followed By Cetuximab and Radiation in HPV-Associated Resectable Stage III/IV Oropharynx CancerCompletedNCT01084083Phase 2Results posted
• Irinotecan Hydrochloride and Cetuximab With or Without Ramucirumab in Treating Patients With Advanced Colorectal Cancer With Progressive Disease After Treatment With Bevacizumab-Containing ChemotherapyCompletedNCT01079780Phase 2Results posted
• Dasatinib in Treating Patients With Locally Advanced or Metastatic Mucosal Melanoma, Acral Melanoma, or Vulvovaginal Melanoma That Cannot Be Removed By SurgeryCompletedNCT00700882Phase 2Results posted
• Chemotherapy, Radiation Therapy, and Cetuximab Followed by Surgery, Docetaxel, and Cetuximab in Treating Patients With Esophageal Cancer or Gastroesophageal Junction CancerTerminatedNCT00551759Phase 2Results posted
• AMG 706 and Octreotide in Treating Patients With Low-Grade Neuroendocrine TumorsCompletedNCT00427349Phase 2Results posted
• Rituximab and Combination Chemotherapy in Treating Patients With Primary Central Nervous System LymphomaTerminatedNCT00335140Phase 2Results posted
• Rituximab and Combination Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Non-Hodgkin's LymphomaCompletedNCT00274924Phase 2Results posted
• Bevacizumab and Combination Chemotherapy in Treating Patients With Peripheral T-Cell Lymphoma or Natural Killer Cell NeoplasmsCompletedNCT00217425Phase 2Results posted
• Cetuximab in Treating Patients With Recurrent or Stage IIIB or Stage IV Lung CancerCompletedNCT00103207Phase 2Results posted
• Pemetrexed Plus Gemcitabine or Carboplatin for Patients With Advanced Malignant Pleural MesotheliomaCompletedNCT00101283Phase 2Results posted
• Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal CancerCompletedNCT00098787Phase 2Results posted
• Phase II Study of Concurrent C225, Cisplatin and Radiation in Stage IV Squamous Cell Carcinoma of the Head and NeckCompletedNCT00096174Phase 2Results posted
• Cetuximab, Chemotherapy, and Radiation Therapy for Operable Stage III or IV Head and Neck CancerCompletedNCT00089297Phase 2Results posted
• Temozolomide and Radiation Therapy in Treating Patients With Brain Metastasis Secondary to Non-Small Cell Lung CancerCompletedNCT00080938Phase 2Results posted
• Rituximab in Treating Patients With Low Tumor Burden Indolent Non-Hodgkin's LymphomaCompletedNCT00075946Phase 3Results posted
• Pentostatin, Cyclophosphamide, and Rituximab Followed By Campath-1H in Patients With Relapsed or Refractory B-Cell CLLCompletedNCT00074282Phase 2Results posted
• Vaccine Therapy Using Melanoma Peptides for Cytotoxic T Cells and Helper T Cells in Treating Patients With Metastatic MelanomaCompletedNCT00071981Phase 2Results posted
• Cyclosporine in Treating Patients With Recurrent or Refractory Angioimmunoblastic T-Cell LymphomaTerminatedNCT00070291Phase 2Results posted
• Doxorubicin and Gemcitabine in Treating Patients With Locally Recurrent or Metastatic Unresectable Renal Cell CarcinomaCompletedNCT00068393Phase 2Results posted
• Sorafenib in Treating Patients With Refractory Non-Small Cell Lung CancerCompletedNCT00064350Phase 2Results posted
• Esophagectomy in Treating Patients With High-Grade Dysplasia of the Esophagus or Stage I, Stage II, or Stage III Esophageal CancerCompletedNCT00063986Phase 2Results posted
• Interferon Alfa, Isotretinoin, and Paclitaxel in Treating Patients With Recurrent Small Cell Lung CancerCompletedNCT00062010Phase 2Results posted
• Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed Waldenstrom's MacroglobulinemiaTerminatedNCT00060346Phase 2Results posted
• Reduced-Intensity Regimen Before Allogeneic Transplant for Patients With Relapsed Non-Hodgkin's or Hodgkin's LymphomaTerminatedNCT00057954Phase 2Results posted
• Gemcitabine With or Without Radiation Therapy in Treating Patients With Pancreatic CancerCompletedNCT00057876Phase 3Results posted
• Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Extensive-Stage Small Cell Lung CancerCompletedNCT00057837Phase 2Results posted
• PEG-Interferon Alfa-2b in Treating Patients With Stage IV MelanomaCompletedNCT00049530Phase 2Results posted
• Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With AML LeukemiaCompletedNCT00049517Phase 3Results posted
• Daunorubicin & Cytarabine +/- Zosuquidar inTreating Older Patients With Newly Diagnosed Acute Myeloid Leukemia or Refractory AnemiaCompletedNCT00046930Phase 3Results posted
• Reduced-Intensity Regimen Before Donor Bone Marrow Transplant in Treating Patients With Myelodysplastic SyndromesCompletedNCT00045305Phase 2Results posted
• Irinotecan and Docetaxel With or Without Cetuximab in Treating Patients With Metastatic Pancreatic CancerCompletedNCT00042939Phase 2Results posted
• Radiation Therapy and Chemotherapy Before and After Surgery in Treating Patients With Esophageal CancerCompletedNCT00033657Phase 2Results posted
• Carboplatin Combined With Paclitaxel in Treating Patients With Advanced ThymomaCompletedNCT00010257Phase 2Results posted
• Methotrexate With or Without Cyclophosphamide in Treating Patients With Lymphocytic LeukemiaTerminatedNCT00003910Phase 2Results posted
• Chemoembolization in Treating Patients With Primary Liver Cancer or Metastases to the LiverCompletedNCT00003907Phase 2Results posted
• Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's LymphomaCompletedNCT00003389Phase 3Results posted
• Erythropoietin (EPO)+/- Filgrastim (G-CSF) vs. Supportive Therapy Alone for Patients With Myelodysplastic SyndromesCompletedNCT00003138Phase 3Results posted
• Phase III rhu_GM-CSF + 3 Induction Regimens in Adults With Acute Non-Lymphocytic LeukemiaCompletedNCT04446052Phase 3
• Double Blind Phase III Trial of Effects of Low Dose 13-Cisretinoic Acid on Prevention of Second Primaries in Stages I-II Head and Neck CancerCompletedNCT03370367Phase 3
• C-Met Inhibitor AMG 337, Oxaliplatin, Leucovorin Calcium, and Fluorouracil in Treating Patients With Advanced Stomach or Esophageal CancerWithdrawnNCT02344810Phase 1/2
• PSA Antibody Levels in Samples From Patients With Prostate Cancer Treated on Protocol ECOG-E9802CompletedNCT01672905
• Studying Genes in Samples From Younger Patients With Acute Lymphoblastic LeukemiaStatus unknownNCT01653613
• Studying Biomarkers in Samples From Patients With Recurrent or Metastatic Head and Neck Cancer Treated on E1302 TrialCompletedNCT01619618
• Biomarkers in Samples From Patients With B-Cell Acute Lymphoblastic LeukemiaCompletedNCT01505699
• Tissue and Blood Biomarkers From Patients With Stage III or Stage IV Melanoma Treated With Ipilimumab With or Without SargramostimCompletedNCT01489423
• Biomarkers in Tissue Samples From Patients With Recurrent or Metastatic Head and Neck Cancer Treated on ECOG-E1395 and ECOG-E3301CompletedNCT01487733
• Biomarkers in Patients With Metastatic or Recurrent Head and Neck Cancer Treated With Cisplatin and Cetuximab on ECOG-E5397CompletedNCT01466244
• Biomarker Study of Chemotherapy Resistance and Outcomes in Samples From Older Patients With Acute Myeloid LeukemiaCompletedNCT01421875
• DNA Analysis in Influencing Response to Rituximab in Samples From Patients With Follicular Lymphoma Treated on ECOG-E4402CompletedNCT01406782
• Biomarkers in Tumor Tissue Samples From Patients With Peripheral T-cell Lymphoma or Natural Killer Cell NeoplasmsCompletedNCT01390597
• Biomarkers in Blood Samples From Patients With Stage IV Melanoma Previously Treated With SargramostimCompletedNCT01388569
• Biomarkers in Blood Samples From Patients With Acute Myeloid LeukemiaCompletedNCT01385150
• Biomarkers in Samples From Patients With Follicular Lymphoma Treated With RituximabCompletedNCT01150643
• Biomarkers in DNA Samples From Patients With Chronic Lymphocytic Leukemia Previously Treated With Fludarabine-Based TherapyCompletedNCT01145469
• Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade GliomaActive, not recruitingNCT00978458Phase 3
• Studying Tumor Tissue Samples to Learn More About DNA Changes and Response in Patients With Breast Cancer Treated With Bevacizumab on Clinical Trial ECOG-2100CompletedNCT00899418
• Studying Blood Samples From Patients With Multiple Myeloma Who Were Treated With Thalidomide or LenalidomideCompletedNCT00899080
• Collecting Tissue Samples From Patients With Leukemia or Other Blood Disorders Planning to Enroll in an ECOG Leukemia Treatment Clinical TrialCompletedNCT00897767
• Study of Bone Marrow Samples From Patients With Acute LeukemiaCompletedNCT00897559
• Identifying Genes That Predict Recurrence in Women With Breast Cancer Treated With ChemotherapyCompletedNCT00897299
• Androgen Ablation Therapy With or Without Vaccine Therapy in Treating Patients With Prostate CancerWithdrawnNCT00771017Phase 2
• Bicalutamide With or Without Enzastaurin in Treating Patients With Prostate CancerWithdrawnNCT00685633Phase 2
• Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced or Refractory Solid TumorsWithdrawnNCT00499291Not applicable
• Enzastaurin, Carboplatin, and Gemcitabine With or Without Bevacizumab in Treating Patients With Recurrent, Stage IIIB, or Stage IV Non-Small Cell Lung CancerWithdrawnNCT00469976Phase 2
• Bevacizumab, Cisplatin, Etoposide, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung CancerCompletedNCT00387699Phase 2
• Gemcitabine in Treating Patients With Metastatic Cancer of Unknown PrimaryCompletedNCT00357630Phase 2
• Quality of Life in Female Breast Cancer Survivors and Their Spouse, Partner, or AcquaintanceCompletedNCT00309933
• Study of Symptoms Caused by Cancer and Cancer Therapy in Patients With Invasive Breast, Lung, Prostate, or Colorectal CancerCompletedNCT00303914
• Vatalanib and Octreotide in Treating Patients With Progressive Neuroendocrine TumorsWithdrawnNCT00227773Phase 2
• Donor Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia in RemissionWithdrawnNCT00101140Phase 2
• Celecoxib in Managing Pain, Weight Loss, and Weakness in Patients With Advanced CancerWithdrawnNCT00093678Not applicable
• Quality of Life in Postmenopausal Women Who Are Receiving Either Exemestane or Anastrozole With or Without Celecoxib for Stage I, Stage II, or Stage IIIA Primary Breast CancerCompletedNCT00090974
• High-Dose Methotrexate and Leucovorin in Treating Patients With Newly Diagnosed Glioblastoma MultiformeCompletedNCT00082797Phase 2
• Paclitaxel and Carboplatin in Treating Patients With Locally Advanced or Metastatic Renal Cell CancerCompletedNCT00077129Phase 2
• Epoetin Alfa With or Without Dexamethasone in Treating Fatigue and Anemia in Patients With Hormone-Refractory Prostate CancerCompletedNCT00060398Phase 3
• Perifosine in Treating Patients With Locally Advanced, Unresectable, or Metastatic Pancreatic CancerCompletedNCT00059982Phase 2
• Gemcitabine With or Without Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Pancreatic CancerCompletedNCT00058149Phase 3
• Isotretinoin, Interferon Alfa, and Vitamin E in Treating Patients With Stage III or Stage IV Head and Neck CancerCompletedNCT00054561Phase 3
• Pemetrexed Disodium and Gemcitabine in Treating Patients With Advanced Cancer of the UrotheliumCompletedNCT00053209Phase 2
• Stem Cell Transplantation With or Without Rituximab in Treating Patients With Relapsed or Progressive B-Cell Diffuse Large Cell LymphomaCompletedNCT00052923Phase 3
• Amifostine and Melphalan in Treating Patients With Primary Systemic Amyloidosis Who Are Undergoing Peripheral Stem Cell TransplantationTerminatedNCT00052884Phase 1
• Chemotherapy and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic CancerCompletedNCT00049348Phase 2
• Combination Chemotherapy in Treating Patients With Advanced Non-Small Cell Lung CancerCompletedNCT00041314Phase 2
• Irinotecan and Docetaxel in Treating Patients With Metastatic or Locally Recurrent Head and Neck CancerCompletedNCT00040807Phase 2
• Atrasentan in Treating Patients With Locally Recurrent or Metastatic Kidney CancerCompletedNCT00039429Phase 2
• Paclitaxel With or Without Bevacizumab in Treating Patients With Locally Recurrent or Metastatic Breast CancerCompletedNCT00028990Phase 3
• Dalteparin and Radiation Therapy in Treating Patients With Newly Diagnosed Supratentorial Glioblastoma MultiformeCompletedNCT00028678Phase 2
• Hormone Therapy Compared With Combination Chemotherapy in Treating Patients With Prostate CancerCompletedNCT00027859Phase 3
• Hormone Replacement Therapy for Hot Flashes and/or Vaginal Symptoms in Postmenopausal Women Receiving Tamoxifen for Breast CancerCompletedNCT00026286Phase 3
• Gefitinib in Treating Patients With Recurrent Metastatic Colorectal CancerCompletedNCT00025350Phase 2

← Eastern Cooperative Oncology Group overview and focus areas